ARCHIVES

Cancer Research Faces A “Strategic Inflection,” NCI Director Says

This article is from The Cancer Letter archive.

Vol. 28 No. 16 | April 19, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Programs: New RAID Program Offers NCI Expertise In Drug Development

April 24, 1998

PhRMA Offers Assistance For Part D “Doughnut Hole”

June 26, 2009

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

February 7, 2014

When Screening Mammography Meets Health Care Reform, Opinions Proliferate

February 4, 1994

NCI CTEP-Approved Trials For the Month of June

June 27, 2014

NIH Study Finds Sigmoidoscopy Reduces Colon Cancer Incidence and Mortality Rates

May 25, 2012